Educational portal · Clinical decisions are made only by licensed physicians in Japan

Synergistic supportive therapies

Gentle supportive therapies designed to work alongside your main immune or targeted treatment.

Supportive treatments that complement the main immune-based or targeted therapy and help shape a more favorable treatment environment.

Non-Invasive 8MHz Oncological Hyperthermia for Deep-Tissue Heating

Expand treatmentCollapse treatment

Oncological Hyperthermia is an advanced, non-invasive physical therapy that uses highly controlled radiofrequency waves to heat tumor tissues to temperatures between 42°C and 43°C. Because tumor tissue often has disorganized structure and poor blood flow, it dissipates heat less effectively than healthy tissue and is therefore relatively more sensitive to it. Raising the tumor temperature can damage cancer cells and impair their DNA repair, and it is used mainly to enhance the effect of chemotherapy, radiation, and immunotherapy.

What is Non-Invasive 8MHz Oncological Hyperthermia?

Oncological Hyperthermia is an advanced, non-invasive physical therapy that uses highly controlled radiofrequency waves to heat tumor tissues to temperatures between 42°C and 43°C. Because tumor tissue often has disorganized structure and poor blood flow, it dissipates heat less effectively than healthy tissue and is therefore relatively more sensitive to it. Raising the tumor temperature can damage cancer cells and impair their DNA repair, and it is used mainly to enhance the effect of chemotherapy, radiation, and immunotherapy.

Why are cancer cells highly sensitive to local heating?

Healthy tissues have a highly organized network of blood vessels that dilate in response to heat, allowing blood to flow quickly and dissipate thermal energy, keeping the tissue at a safe temperature. Tumors, however, have a chaotic, poorly constructed network of blood vessels that cannot dilate. When exposed to radiofrequency energy, the heat becomes trapped within the tumor, quickly raising its temperature into a therapeutic range of about 42°C to 43°C:

  1. Direct Cellular Damage: The elevated heat directly denatures critical proteins within the cancer cells, disrupts cell membranes, and damages their mitochondria, halting energy production and causing the cancer cells to die.
  2. Inhibition of DNA Repair: Heat inactivates the key enzymes cancer cells use to repair their DNA. This makes cancer cells exceptionally vulnerable, significantly boosting the cell-killing power of radiation and chemotherapy.
  3. Immunological Activation: Thermal stress causes cancer cells to release Heat Shock Proteins (HSP70). These proteins act as powerful danger signals that attract and activate dendritic cells, natural killer (NK) cells, and cytotoxic T-lymphocytes, triggering a powerful, systemic anti-tumor immune response.
  4. Improved Oxygenation: The heat increases blood flow to the surrounding tumor area, delivering more oxygen to the tissue. This reverses tumor hypoxia, which is a major driver of resistance to radiation and chemotherapy.

What does a clinical hyperthermia session look like?

The treatment is performed using highly advanced, specialized medical systems, such as the Thermotron RF8, which is widely utilized in clinical settings. The patient relaxes comfortably on a specialized treatment bed while the targeted tumor area is positioned between two external radiofrequency electrodes. A high-frequency 8MHz radiofrequency current is passed between the electrodes, generating precise, deep-tissue friction heat directly within the tumor.

A standard session lasts approximately 50 to 60 minutes and is completely non-invasive, requiring no anesthesia. Treatments are typically administered 1 to 2 times per week, often scheduled in close coordination with immunotherapy or low-dose chemotherapy sessions to maximize therapeutic success. Side effects are minimal, occasionally limited to temporary skin redness or mild sweating.

Scientific Evidence & Literature

Synergetic Thermal and Immunotherapy Integration

Expand treatmentCollapse treatment

Synergetic Thermal Therapy is a protocol that combines local or systemic hyperthermia with other cancer treatments such as chemotherapy, radiation, and cellular immunotherapies. Rather than using heat on its own, it applies thermal energy to alter the tumor and its microenvironment. The aim is to enhance the effect of the accompanying therapies, which in some settings allows lower chemotherapy doses to be used.

What is Synergetic Thermal and Immunotherapy Integration?

Synergetic Thermal Therapy is a protocol that combines local or systemic hyperthermia with other cancer treatments such as chemotherapy, radiation, and cellular immunotherapies. Rather than using heat on its own, it applies thermal energy to alter the tumor and its microenvironment. The aim is to enhance the effect of the accompanying therapies, which in some settings allows lower chemotherapy doses to be used.

How does thermal stress enhance the effectiveness of other cancer treatments?

The power of Synergetic Thermal Therapy lies in its ability to simultaneously overcome multiple major resistance mechanisms within the tumor microenvironment:

  • Synergy with Chemotherapy: Moderate heat increases the permeability of cancer cell membranes, allowing chemotherapy drugs to easily enter and accumulate inside the cells. This significantly boosts the drug's cancer-killing power, allowing doctors to use lower, low-dose chemotherapy protocols that protect the patient's overall health and quality of life.
  • Synergy with Radiotherapy: Radiation requires oxygen to produce the free radicals that destroy cancer cell DNA. Because tumors are often hypoxic (lacking oxygen), they are highly resistant to radiation. Thermal therapy dilates blood vessels around the tumor, delivering a rush of oxygenated blood that reverses hypoxia and makes the tumor exceptionally vulnerable to radiation.
  • Synergy with Cellular Immunotherapy: Thermal stress prompts cancer cells to express Heat Shock Proteins (HSP70) at their surface. These chaperones bind tumor antigens and can make it easier for dendritic cells to take up and process those markers. This is the rationale for pairing hyperthermia with the Multivalent Dendritic Cell Vaccine and Activated NK Cell Therapy to support a more coordinated systemic immune response.

How is this integrated therapy scheduled clinically?

The therapy is carefully coordinated and timed to align with the patient's primary treatment schedule. A typical session involves performing localized hyperthermia (using advanced radiofrequency heating systems) immediately before or during the administration of intravenous immunotherapies, high-concentration vitamin C, or low-dose chemotherapy.

The treatment is performed on an outpatient basis. Because it is non-invasive and monitored by clinical staff, it is generally well tolerated and designed to preserve quality of life throughout the treatment course.

Scientific Evidence & Literature

Clinical Molecular Hydrogen Inhalation Therapy for Oxidative Stress Management

Expand treatmentCollapse treatment

Hydrogen Inhalation Therapy is a supportive treatment in which the patient inhales high-purity molecular hydrogen (H2) gas through a nasal cannula. Molecular hydrogen is a small molecule that diffuses readily into cells and is proposed to act as a selective antioxidant. It is being studied mainly as supportive care, with the aim of neutralizing certain reactive free radicals, reducing inflammation, and easing side effects of chemotherapy and radiation; the clinical evidence remains limited and largely preliminary.

What is Clinical Molecular Hydrogen Inhalation Therapy?

Hydrogen Inhalation Therapy is a supportive treatment in which the patient inhales high-purity molecular hydrogen (H2) gas through a nasal cannula. Molecular hydrogen is a small molecule that diffuses readily into cells and is proposed to act as a selective antioxidant. It is being studied mainly as supportive care, with the aim of neutralizing certain reactive free radicals, reducing inflammation, and easing side effects of chemotherapy and radiation; the clinical evidence remains limited and largely preliminary.

How does molecular hydrogen function as a selective antioxidant?

During conventional cancer treatments, stress, and chronic inflammation, the body produces massive amounts of Reactive Oxygen Species (ROS), also known as free radicals. While some of these free radicals play important roles in cellular signaling, highly reactive species—such as the hydroxyl radical (•OH) and peroxynitrite (ONOO-)—cause severe oxidative damage, destroying cellular DNA, lipids, and proteins, which leads to healthy tissue damage and intense fatigue.

Molecular hydrogen (H2) is the smallest molecule in existence. This unique property allows it to easily pass through cell membranes, cross the blood-brain barrier, and penetrate deep into cell nuclei and mitochondria:

  1. Selective Antioxidant Action: Unlike standard antioxidants (like Vitamin E or C), which neutralize all free radicals non-selectively, molecular hydrogen selectively targets and neutralizes only the most toxic, cell-damaging free radicals, such as hydroxyl radicals (•OH), converting them into completely harmless water molecules (H2O).
  1. Upregulation of Antioxidant Enzymes: Molecular hydrogen activates key cellular defense mechanisms (such as the Nrf2 pathway) that trigger the body's own production of powerful antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione.
  2. Anti-Inflammatory Effects: Hydrogen has been reported to lower markers of inflammation (such as IL-6 and CRP), which may help protect healthy organs from chemotherapy-related toxicity. Preclinical data suggest this does not blunt the cytotoxic effect of the cancer treatment itself, though this has not been firmly established in patients.

What does a hydrogen inhalation session look like?

The therapy is non-invasive and painless. The patient sits comfortably while inhaling medical-grade hydrogen gas (typically a 2% to 4% concentration, kept below the flammability threshold) through a soft nasal cannula.

Sessions typically last 60 minutes and may be performed daily or several times per week, often alongside intravenous vitamin C, hyperthermia, or cellular immunotherapies. Molecular hydrogen inhalation has a good safety record in reported studies, with few adverse effects described.

Scientific Evidence & Literature

High-Concentration Intravenous Vitamin C (IVC) Therapy for Selective Oncology Support

Expand treatmentCollapse treatment

High-Concentration Vitamin C Infusion Therapy involves the slow intravenous administration of very high doses of pharmaceutical-grade ascorbic acid, typically ranging from 30g to 90g per session. Whereas oral vitamin C behaves as an antioxidant, the very high blood levels achievable only by intravenous infusion can shift ascorbate toward pro-oxidant activity, generating hydrogen peroxide in the tissue space. In laboratory and early clinical studies this can damage catalase-poor cancer cells while sparing catalase-rich normal cells. This mechanism is still investigational, and IVC is used here as supportive rather than curative care.

What is High-Concentration Intravenous Vitamin C (IVC) Therapy?

High-Concentration Vitamin C Infusion Therapy involves the slow intravenous administration of very high doses of pharmaceutical-grade ascorbic acid, typically ranging from 30g to 90g per session. Whereas oral vitamin C behaves as an antioxidant, the very high blood levels achievable only by intravenous infusion can shift ascorbate toward pro-oxidant activity, generating hydrogen peroxide in the tissue space. In laboratory and early clinical studies this can damage catalase-poor cancer cells while sparing catalase-rich normal cells. This mechanism is still investigational, and IVC is used here as supportive rather than curative care.

How does high-dose vitamin C selectively target cancer cells?

When vitamin C is administered intravenously in high doses, it bypasses the body's normal digestive limits, reaching therapeutic concentrations in the blood that are impossible to achieve through oral intake:

  1. Hydrogen Peroxide Generation: In the extracellular space around tissues, high concentrations of ascorbate react with trace metals (such as iron or copper) to generate hydrogen peroxide (H2O2).
  2. Selective Oxidative Stress: Hydrogen peroxide diffuses into cells and raises oxidative stress. Normal cells express high levels of catalase, an enzyme that breaks hydrogen peroxide down into water and oxygen.
  3. Malignant Cell Destruction: Cancer cells are highly deficient in catalase. Because they cannot neutralize the hydrogen peroxide, it accumulates rapidly inside the cancer cells, damaging their DNA, disrupting their mitochondria, and cutting off their ATP energy production, causing selective cell death.
  4. Collagen and Immune Support: Beyond its direct cancer-killing effects, vitamin C supports the production of collagen, helping to strengthen the healthy tissues surrounding tumors to prevent cancer from spreading. It also boosts the activity of natural killer (NK) cells and cytotoxic T-lymphocytes, supporting the body's natural defenses.

What does the standard clinical infusion involve?

Before beginning the therapy, patients undergo a simple blood test to screen for G6PD deficiency (Glucose-6-Phosphate Dehydrogenase deficiency); this screening is critical, as G6PD is required to maintain red blood cell integrity during high-dose vitamin C infusions.

Once cleared, the vitamin C formulation is given by slow intravenous infusion over 60 to 90 minutes. A standard supportive protocol consists of infusions 1 to 2 times per week over about 3 months, performed on an outpatient basis. Minor, temporary side effects are easily managed and include localized vein irritation (managed by adjusting the infusion speed) or mild thirst due to the formulation's natural diuretic effect.

Scientific Evidence & Literature

Let’s look at your options in Japan

Send us your diagnosis and recent medical records. A coordinator will review your case, explain what may be possible at our partner clinics, and guide you through every step — free of charge and with no obligation.

No treatment is promised or guaranteed. Clinical suitability can only be determined by a licensed physician after reviewing the relevant medical information.